Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2025)
Nuwellis (NUWE) posted Amortization of Deferred Charges of -$10.3 million for Q4 2025, down 197.94% on a QoQ basis from $10.6 million in Q2 2025, and down 6790.67% year-over-year from $154483.9 in Q4 2024.
Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2025) Analysis & Trends
Nuwellis' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at -$10.3 million for Q4 2025.
- Quarterly Amortization of Deferred Charges fell 6790.67% year-over-year to -$10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67000.0 (down 99.25% YoY) and the FY2025 annual result came in at $217000.0, changed N/A from the prior year.
- Amortization of Deferred Charges was -$10.3 million for Q4 2025 at Nuwellis, down from $10.6 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $10.6 million in Q2 2025 and bottomed at -$10.3 million in Q4 2025.
- A 3-year average of $1.8 million and a median of $3.5 million in 2023 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 88.21% in 2025, while the deepest fall reached 6790.67% in 2025.
- Nuwellis' Amortization of Deferred Charges stood at $3.5 million in 2023, then plunged by 104.31% to -$150000.0 in 2024, then tumbled by 6790.67% to -$10.3 million in 2025.
- Business Quant data shows NUWE's Amortization of Deferred Charges at -$10.3 million in Q4 2025, $10.6 million in Q2 2025, and -$150000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Nuwellis | 118,572.00 | -1.96 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.34 Mn |
| Dec 31, 2025 | -10.34 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Dec 31, 2024 | -150,000.00 |
| Dec 31, 2024 | -150,000.00 |
| Jun 30, 2024 | 5.61 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Dec 31, 2023 | 3.48 Mn |